Health ❯Vaccines

RSV

MPOX hMPV Nirsevimab Hospital Admissions Infection NHS Study Federal Regulators

Shortage of New RSV Treatment Nirsevimab Amid High Demand

AstraZeneca to Acquire Icosavax for $1.1 Billion